We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$510B
AUM Growth
+$42.9B
Cap. Flow
+$3.32B
Cap. Flow %
0.65%
Top 10 Hldgs %
23.33%
Holding
4,244
New
144
Increased
2,112
Reduced
1,496
Closed
90

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$420M
2
ZM icon
Zoom
ZM
+$370M
3
UBER icon
Uber
UBER
+$267M
4
INTC icon
Intel
INTC
+$247M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$143M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$421M
2
ABBV icon
AbbVie
ABBV
+$266M
3
AMGN icon
Amgen
AMGN
+$212M
4
PPLI
People Inc
PPLI
+$207M
5
LLY icon
Eli Lilly
LLY
+$100M

Sector Composition

Rank Sector Weight
1 Technology 24.49%
2 Healthcare 14.08%
3 Financials 12.39%
4 Consumer Discretionary 12.01%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
976
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$45M 0.01%
692,710
+36,174
+6% +$2.37M
BOX icon
977
Box
BOX
$4.56B
$45M 0.01%
2,593,064
-61,054
-2% -$1.13M
RPD icon
978
Rapid7
RPD
$731M
$45M 0.01%
734,727
+25,666
+4% +$1.53M
CRI icon
979
Carter's
CRI
$1.48B
$44.9M 0.01%
518,617
+25,051
+5% +$2.09M
MOG.A icon
980
Moog Inc Class A
MOG.A
$12.7B
$44.8M 0.01%
705,105
+153,724
+28% +$8.87M
SKX
981
DELISTED
Skechers
SKX
$44.7M 0.01%
1,480,761
-76,910
-5% -$2.29M
IRDM icon
982
Iridium Communications
IRDM
$5.22B
$44.7M 0.01%
1,746,975
+108,189
+7% +$2.98M
EYE icon
983
National Vision
EYE
$1.82B
$44.6M 0.01%
1,166,036
-16,773
-1% -$583K
TKR icon
984
Timken Company
TKR
$8.99B
$44.5M 0.01%
820,784
+3,048
+0.4% +$157K
SYNH
985
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$44.5M 0.01%
837,004
+31,216
+4% +$1.86M
ACIW icon
986
ACI Worldwide
ACIW
$5.57B
$44.3M 0.01%
1,696,602
-62,665
-4% -$1.73M
HEI icon
987
HEICO Corp
HEI
$50.8B
$44.3M 0.01%
423,975
-174,087
-29% -$18M
FATE icon
988
Fate Therapeutics
FATE
$291M
$44.1M 0.01%
1,103,490
+72,164
+7% +$2.52M
ENS icon
989
EnerSys
ENS
$6.86B
$44.1M 0.01%
656,663
-29,126
-4% -$2M
CCOI icon
990
Cogent Communications
CCOI
$501M
$44M 0.01%
732,828
+9,092
+1% +$663K
RBC icon
991
RBC Bearings
RBC
$17.8B
$43.6M 0.01%
359,931
-9,051
-2% -$1.16M
SLM icon
992
SLM Corp
SLM
$5.13B
$43.5M 0.01%
5,374,630
-23,922
-0.4% -$175K
BBIO icon
993
BridgeBio Pharma
BBIO
$16.3B
$43.5M 0.01%
1,158,655
+425,720
+58% +$13.4M
TGTX icon
994
TG Therapeutics
TGTX
$7.61B
$43.5M 0.01%
1,623,842
+123,295
+8% +$2.84M
GMED icon
995
Globus Medical
GMED
$11.1B
$43.3M 0.01%
873,730
-46,937
-5% -$2.42M
SLF icon
996
Sun Life Financial
SLF
$44.7B
$43.2M 0.01%
1,052,719
+27,022
+3% +$1.09M
HOG icon
997
Harley-Davidson
HOG
$2.73B
$43.2M 0.01%
1,761,488
-75,049
-4% -$2.02M
HASI icon
998
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.21B
$43.2M 0.01%
1,022,024
-14,371
-1% -$536K
HLI icon
999
Houlihan Lokey
HLI
$9.05B
$43.2M 0.01%
731,319
+14,936
+2% +$856K
SBRA icon
1000
Sabra Healthcare REIT
SBRA
$5.34B
$43.2M 0.01%
3,132,337
-95,051
-3% -$1.4M

Similar funds

Geode Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Geode Capital Management held 4,244 positions worth $510B, up 9.2% from $467B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2020 filing shows 144 new, 2,112 increased, 1,496 reduced and 90 closed positions. Its largest new stake was Snowflake: 195,170 shares worth $48.9M. The largest sale was Apple, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q3 2020 buy was Snowflake: 195,170 shares worth $48.9M.
  • Geode Capital Management added most to Amazon in Q3 2020, an estimated $420M increase.
  • Geode Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $421M.
  • Geode Capital Management fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $84.5M.
  • Geode Capital Management's ten largest holdings make up 23% of its $510B portfolio in Q3 2020.
  • Geode Capital Management opened 144 new positions and closed 90 in Q3 2020.
  • Geode Capital Management's portfolio value rose 9.2% quarter-over-quarter to $510B.

Based on Geode Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.